Vascular changes, cardiovascular disease and obstructive sleep apnea (Q37859758)

24 August 2017

1 reference

title

Vascular changes, cardiovascular disease and obstructive sleep apnea (English)

1 reference

24 August 2017

cardiovascular disease

1 reference

Kannan Ramar

1

1 reference

PubMed ID

21453030

24 August 2017

Sean M Caples

series ordinal

2

1 reference

24 August 2017

1 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

7

1 reference

24 August 2017

2

1 reference

24 August 2017

241-249

1 reference

The occurrence of sleep-disordered breathing among middle-aged adults

24 August 2017

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Sleep apnea and heart failure: Part I: obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Pulmonary edema develops after recurrent obstructive apneas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Impact of treatment of sleep apnoea on left ventricular function in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Sympathetic neural mechanisms in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Renin activity and blood pressure in response to chronic episodic hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Role of endothelin in intermittent hypoxia-induced hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Effects of obstructive sleep apnea on endothelin-1 and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Plasma levels of vascular endothelial markers in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Structure and function of xanthine oxidoreductase: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Uric acid and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Estrogen modulates xanthine dehydrogenase/xanthine oxidase activity by a receptor-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Abnormal lipid peroxidation in patients with sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Oxidative stress in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Antioxidant capacity in obstructive sleep apnea patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Sleep apnea and markers of vascular endothelial function in a large community sample of older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Antioxidant vitamin C improves endothelial function in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Leptin and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Leptin enhances the calcification of vascular cells: artery wall as a target of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Leptin promotes vascular remodeling and neointimal growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Vascular-bed--specific hemostasis and hypercoagulable states

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Elevated C-reactive protein in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Cellular adhesion molecules and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Delayed neutrophil apoptosis in patients with sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Early signs of atherosclerosis in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Expert consensus document on arterial stiffness: methodological issues and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Atherosclerosis in obstructive sleep apnoea: it does not matter whether patients are sleepy or not.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

CPAP and measures of cardiovascular risk in males with OSAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Obstructive sleep apnea and atherosclerosis: a new paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

Effects of long-term treatment for obstructive sleep apnea on pulse wave velocity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFCA.10.123

21 January 2018

Identifiers

DOI

10.2217/FCA.10.123

1 reference

24 August 2017

1 reference

PubMed ID

21453030